Search results
Targeting 'monster cancer cells' could reduce recurrence rates after cancer therapy
Medical Xpress· 1 day agoBoth types of therapy put cancer cells under stress, with the goal of causing them to self-destruct. Recently, scientists have begun to look at the role of polyploid giant ...
Could a medicated foam make gene therapies more ac | Newswise
Newswise· 17 hours agoNow, Fred Hutch Cancer Center scientists have found that foam might also be used as a vehicle to...
Bacterial model helps reveal how our bodies prevent population explosions—and cancer
Phys.org· 1 day agoIt follows that a balance between dividing and mature cells is a precondition for the existence of any multicellular organism, but how is it maintained? In a new study published recently in ...
Multi-wall carbon Nanotube surface-based functional nanoparticles for stimuli-responsive dual...
Nature· 3 days agoThe findings demonstrated the efficacy of using ƒ-MWCNT-CUR-BSA-MTX as a vehicle for efficient co-delivery of CUR and MTX in cancer treatment. The MTT colorimetric method ...
Heart healthy behaviors may help reverse rapid cell aging
NewMediaWire via Yahoo Finance· 13 hours agoResearch Highlights: The benefits gained from better heart health may be related to a process...
Galvanize Therapeutics' endoscopic, pulsed-field needle scores FDA clearance in cancer, soft tissue...
FierceBiotech· 1 day agoAccording to Galvanize—which billed its forthcoming system as the first commercial product to...
PKMYT1, a potential 'Achilles heel' of treatment resistant ER+ breast cancers with the poorest...
Medical Xpress· 5 days agoLooking to identify new vulnerabilities in this type of cancer that could lead to improved...
Tumor mutations may not predict response to immunotherapy, study finds
Medical Xpress· 6 days agoThe findings, published in Nature Cancer, upend long-held conventional wisdom and could lead to more effective ways of deciding which patients will benefit most from this ...
FDA approves first DLL3 × CD3 bispecific T-cell engager for lung cancer
Nature· 6 days agoDiscover the world’s best science and medicine | Nature.com
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive new results from an ongoing Phase 1/2 trial evaluating its first-in-class costimulatory bispecific antibody, REGN7075 ...